Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001641172-25-025588
Filing Date
2025-08-26
Accepted
2025-08-26 17:25:52
Documents
16

Document Format Files

Seq Description Document Type Size
1 S-3 forms-3.htm S-3 392599
2 EX-23.1 ex23-1.htm EX-23.1 7952
3 CALCULATION OF FILING FEE TABLES ex107.htm   iXBRL EX-FILING FEES 24849
4 GRAPHIC forms-3_001.jpg GRAPHIC 8478
5 GRAPHIC ex23-1_001.jpg GRAPHIC 21176
6 GRAPHIC ex23-1_002.jpg GRAPHIC 19254
  Complete submission text file 0001641172-25-025588.txt   617849

Data Files

Seq Description Document Type Size
18 EXTRACTED XBRL INSTANCE DOCUMENT ex107_htm.xml XML 5722
Mailing Address 245 MAIN STREET SUITE 204 CHESTER NJ 07930
Business Address 1200 ROUTE 22 EAST BRIDGEWATER NJ 08807 302-743-2995
Tharimmune, Inc. (Filer) CIK: 0001861657 (see all company filings)

EIN.: 842642541 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-289869 | Film No.: 251258805
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)